(Q36135184)

12 August 2017

Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancer (English)

1 reference

12 August 2017

1 reference

Díez M

1

1 reference

12 August 2017

Torres A

2

1 reference

12 August 2017

Maestro ML

3

1 reference

12 August 2017

Ortega MD

4

1 reference

12 August 2017

Gómez A

5

1 reference

12 August 2017

Pollán M

6

1 reference

12 August 2017

Lopez JA

7

1 reference

12 August 2017

Picardo A

8

1 reference

12 August 2017

Hernando F

9

1 reference

12 August 2017

Balibrea JL

10

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 May 1996

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

73

1 reference

12 August 2017

10

1 reference

12 August 2017

1248-1254

1 reference

Use of tumor markers in lung cancer

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074500

Chemotherapy and radiation for the treatment of non-small-cell lung cancer. A critical review

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074500

Prognostic significance of serum CA 125 antigen assay in patients with non-small cell lung cancer.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074500

Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074500

Prognostic factors in patients with resected stage I non-small cell lung cancer. A report from the Lung Cancer Study Group

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074500

A new international staging system for lung cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074500

Surgical treatment of lung cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074500

The future of prognostic factors in outcome prediction for patients with cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074500

Serum CEA, CA125, and SCC antigens and tumor recurrence in resectable non-small cell lung cancer

2 October 2017

1 reference

12 December 2020

Decline of posttreatment tumor marker levels after therapy of nonsmall cell lung cancer. A useful outcome predictor

1 reference

12 December 2020

Serial plasma carcinoembryonic antigen measurement for monitoring patients with advanced lung cancer during chemotherapy

1 reference

12 December 2020

1 reference

12 December 2020

Prognostic Factors in Lung Cancer

1 reference

12 December 2020

Clinical usefulness of serum assays of neuron-specific enolase, carcinoembryonic antigen and CA-50 antigen in the diagnosis of lung cancer

1 reference

12 December 2020

Serum tumor markers CEA, CA 50, TATI, and NSE in lung cancer screening

1 reference

12 December 2020

Squamous cell carcinoma antigen (SCC Ag) in the diagnosis and prognosis of lung cancer

1 reference

12 December 2020

Quantitative analysis of carcinoembryonic antigen, squamous cell carcinoma antigen, CA 125, and CA 50 cytosolic content in non-small cell lung cancer

1 reference

12 December 2020

Future directions in the treatment of non-small cell lung cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1996.239

1 reference

Dimensions Publication ID

12 August 2017

0 references

1 reference

12 August 2017

PubMed publication ID

8630287

1 reference